Jeff Cehelsky

Viral Load Drives Disease in Humans Experimentally Infected with Respiratory Syncytial Virus

John P. DeVincenzo, Tom Wilkinson, Akshay Vaishnaw et al. · American Journal of Respiratory and Critical Care Medicine · 2010 · 330 citations · Full text

Evaluation of the safety, tolerability and pharmacokinetics of ALN-RSV01, a novel RNAi antiviral therapeutic directed against respiratory syncytial virus (RSV)

John P. DeVincenzo, Jeff Cehelsky, Rene Alvarez et al. · Antiviral Research · 2008 · 245 citations

Respiratory Syncytial Virus, Neurovirology, Pharmacology +9

Phase II trial of intravenous lobradimil and carboplatin in childhood brain tumors: a report from the Children’s Oncology Group

Katherine E. Warren, Regina I. Jakacki, Brigitte C. Widemann et al. · Cancer Chemotherapy and Pharmacology · 2006 · 121 citations

Neuro-oncology, Pediatric Brain Tumors, Phase Ii Trial +7

Respiratory Syncytial Virus Human Experimental Infection Model: Provenance, Production, and Sequence of Low-Passaged Memphis-37 Challenge Virus

Young‐In Kim, John P. DeVincenzo, Bart G. Jones et al. · PLoS ONE · 2014 · 55 citations · Full text

Vaccination, Viral Evolution, Molecular Virology +15

Phase I dose-escalation study of ALN-VSP02, a novel RNAi therapeutic for solid tumors with liver involvement.

Andrés Cervantes, María Alsina, Josep Tabernero et al. · Journal of Clinical Oncology · 2011 · 54 citations

Solid Tumors, Liver Involvement, Novel Rnai Therapeutic +17